Kenji Ohgane

830 total citations
38 papers, 559 citations indexed

About

Kenji Ohgane is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Kenji Ohgane has authored 38 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Surgery. Recurrent topics in Kenji Ohgane's work include Ubiquitin and proteasome pathways (7 papers), Protein Degradation and Inhibitors (6 papers) and Lysosomal Storage Disorders Research (5 papers). Kenji Ohgane is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Protein Degradation and Inhibitors (6 papers) and Lysosomal Storage Disorders Research (5 papers). Kenji Ohgane collaborates with scholars based in Japan, United States and Australia. Kenji Ohgane's co-authors include Yuichi Hashimoto, Kosuke Dodo, Minoru Ishikawa, Shusuke Tomoshige, S. Nomura, H. YOSHIOKA, Tomomi Noguchi‐Yachide, Ngee Kiat Chua, Andrew J. Brown and Hudson W. Coates and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Kenji Ohgane

34 papers receiving 553 citations

Peers

Countries citing papers authored by Kenji Ohgane

Since Specialization

Citations

This map shows the geographic impact of Kenji Ohgane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ohgane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ohgane more than expected).

Fields of papers citing papers by Kenji Ohgane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Ohgane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ohgane. The network helps show where Kenji Ohgane may publish in the future.

Co-authorship network of co-authors of Kenji Ohgane

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Ohgane. A scholar is included among the top collaborators of Kenji Ohgane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Ohgane. Kenji Ohgane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In-gel refolding allows fluorescence detection of fully denatured GFPs after SDS-PAGE 2025 ·Analytical Biochemistry ·(unknown), (unknown), Miwako Asanuma, (unknown), H. YOSHIOKA, Kenji Ohgane	0
2	Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapies 2024 ·JCI Insight ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Brandon L. Ashfeld, Paul Helquist, Olaf Wiest, Kenji Ohgane, Qingqing Li, Ross A. Fredenburg, Brian S. J. Blagg, Stephanie M. Cologna, Mark L. Schultz, Andrew P. Lieberman	0
3	Plakevulin A induces apoptosis and suppresses IL-6-induced STAT3 activation in HL60 cells 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Kaori Kanemaru, (unknown), (unknown), Kenji Yamatoya, Kazuya Nakata, Yoshikazu Nakamura, Shusuke Tomoshige, Kenji Ohgane, (unknown), Ryoko Takasawa, Susumu Kobayashi, Fumio Sugawara, Masahiko Ikekita, Kouji Kuramochi	1
4	Lysine long-chain fatty acylation regulates the TEAD transcription factor 2023 ·Cell Reports ·(unknown), Takehiro Suzuki, Kosuke Dodo, Kenji Ohgane, (unknown), (unknown), Satoshi Morita, Takashi Umehara, Kenji Ogawa, Mikiko Sodeoka, Naoshi Dohmae, Minoru Yoshida, Akihiro Ito	5
5	Fine-tuning of nitrogen-containing bisphosphonate esters that potently induce degradation of HMG-CoA reductase 2022 ·Bioorganic & Medicinal Chemistry ·(unknown), H. YOSHIOKA, (unknown), Tomoko Yajima, (unknown), Kouji Kuramochi, Kenji Ohgane	2
6	Deuteration of terminal alkynes realizes simultaneous live cell Raman imaging of similar alkyne-tagged biomolecules 2021 ·Organic & Biomolecular Chemistry ·Syusuke Egoshi, Kosuke Dodo, Kenji Ohgane, Mikiko Sodeoka	24
7	Epo-C12 inhibits peroxiredoxin 1 peroxidase activity 2021 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Satoshi Arai, Akinori Morita, Kenji Yamatoya, Kazuya Nakata, Shusuke Tomoshige, Kenji Ohgane, (unknown), Kengo Sakaguchi, Fumio Sugawara, Susumu Kobayashi, Masahiko Ikekita, Kouji Kuramochi	2
8	Image-based screen capturing misfolding status of Niemann-Pick type C1 identifies potential candidates for chaperone drugs 2020 ·PLoS ONE ·(unknown), (unknown), H. YOSHIOKA, Tomomi Noguchi‐Yachide, Minoru Ishikawa, Kosuke Dodo, Yuichi Hashimoto, Mikiko Sodeoka, Kenji Ohgane	12
9	A key mammalian cholesterol synthesis enzyme, squalene monooxygenase, is allosterically stabilized by its substrate 2020 ·Proceedings of the National Academy of Sciences ·H. YOSHIOKA, Hudson W. Coates, Ngee Kiat Chua, Yuichi Hashimoto, Andrew J. Brown, Kenji Ohgane	57
10	Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton 2019 ·Bioorganic & Medicinal Chemistry ·(unknown), Kenji Ohgane, H. YOSHIOKA, Makoto Makishima, Yuichi Hashimoto, Tomomi Noguchi‐Yachide	6
11	Multiplexing fluorogenic esterase-based viability assay with luciferase assays 2019 ·MethodsX ·Kenji Ohgane, H. YOSHIOKA, Yuichi Hashimoto	6
12	Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteins 2019 ·Bioorganic & Medicinal Chemistry ·Hiroko Yamashita, Shusuke Tomoshige, S. Nomura, Kenji Ohgane, Yuichi Hashimoto, Minoru Ishikawa	18
13	Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative 2018 ·Bioorganic & Medicinal Chemistry Letters ·Shusuke Tomoshige, S. Nomura, Kenji Ohgane, Yuichi Hashimoto, Minoru Ishikawa	39
14	Unexpected Emergence of Luciferase-Inhibitory Activity During Structural Development Study of Phenyloxadiazole-Based Ppar Ligands 2018 ·Heterocycles ·Kenji Ohgane, (unknown), (unknown), Tomomi Noguchi‐Yachide, Minoru Ishikawa, Takao Yamaguchi, Makoto Makishima, Yuichi Hashimoto	1
15	Reactivity of 7‐Azanorbornenes in Bioorthogonal Inverse Electron‐Demand Diels–Alder Reactions 2017 ·European Journal of Organic Chemistry ·(unknown), Kenji Ohgane, (unknown), Kennosuke Itoh, H. Fujii	3
16	Discovery of Small Molecules that Induce the Degradation of Huntingtin 2017 ·Angewandte Chemie International Edition ·Shusuke Tomoshige, S. Nomura, Kenji Ohgane, Yuichi Hashimoto, Minoru Ishikawa	105
17	Structure–activity relationships of oxysterol-derived pharmacological chaperones for Niemann–Pick type C1 protein 2014 ·Bioorganic & Medicinal Chemistry Letters ·Kenji Ohgane, (unknown), Tomomi Noguchi‐Yachide, Kosuke Dodo, Yuichi Hashimoto	20
18	Discovery of Oxysterol-Derived Pharmacological Chaperones for NPC1: Implication for the Existence of Second Sterol-Binding Site 2013 ·Chemistry & Biology ·Kenji Ohgane, (unknown), Kosuke Dodo, Yuichi Hashimoto	55
19	Structure–activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effect 2013 ·Bioorganic & Medicinal Chemistry ·(unknown), Kenji Ohgane, Kosuke Dodo, Yuichi Hashimoto	12
20	Retinobenzaldehydes as proper-trafficking inducers of folding-defective P23H rhodopsin mutant responsible for Retinitis Pigmentosa 2010 ·Bioorganic & Medicinal Chemistry ·Kenji Ohgane, Kosuke Dodo, Yuichi Hashimoto	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact